COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios, Secretaría de Salud)
Is NAD+ legal in Mexico?
Not approvedNo registration for NAD+ as an injectable medicine found in COFEPRIS lists
Not approved as a medicine here.
No medicine listing NAD+ (nicotinamide adenine dinucleotide) as its active ingredient appears in COFEPRIS's yearly lists of allopathic registrations issued from 2007 to 2026 that we searched, and the 2026 list of new applications has no entry for it. We did not assess oral supplements or precursors, which fall under different rules. COFEPRIS's alerts state that a medicine needs a sanitary registration before it can be sold in Mexico and that prescription drugs are governed by Article 226 of the Ley General de Salud. Human evidence for injected NAD+ is small.
Last verified 2026-09-29 · how we verify
NAD+ elsewhere
Sources (4)
- 01Registros sanitarios de medicamentos alopáticos expedidos 2026COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) · 2026-08-04 · accessed 2026-09-29
- 02Listados de registros sanitarios de medicamentos (visor y listas anuales)COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) · 2025-08-21 · accessed 2026-09-29
- 03Solicitudes de medicamentos (excepto genérico y biocomparable) ingresadas en 2026COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) · 2026-08-31 · accessed 2026-09-29
- 04Alerta sanitaria: comercialización ilegal de productos con tirzepatida sin registro sanitarioCOFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) · 2026-02-09 · accessed 2026-09-29